Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Curanex Pharmaceuticals Inc (CURX) had Return on Tangible Equity of -37.66% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-4.23M |
|
-- |
|
-- |
|
$4.24M |
|
$-4.24M |
|
$0.01M |
|
$-4.23M |
|
$-4.23M |
|
$-4.23M |
|
$-4.23M |
|
$-4.23M |
|
$-4.23M |
|
$-4.24M |
|
$-4.16M |
|
25.50M |
|
25.50M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$11.23M |
|
-- |
|
$0.35M |
|
$11.58M |
|
$0.14M |
|
-- |
|
$0.22M |
|
$0.36M |
|
$11.22M |
|
$11.22M |
|
$11.22M |
|
28.34M |
|
| Cash Flow Statement Financials | |
$-10.48M |
|
-- |
|
$15.31M |
|
$0.15M |
|
$4.97M |
|
$4.82M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
81.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.48M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-37.66% |
|
|
Return on Tangible Equity |
-37.66% |
-36.49% |
|
-37.66% |
|
$0.40 |
|
$-0.41 |
|
$-0.41 |
|